Studies focusing on the pathogenesis of PE and PAH, described that soluble endoglin binds TGF-β, even in the circulation, and thus inhibits its signaling activity, thus, at least in part, explaining the role of soluble endoglin in PE and PAH [59,60]. Here, TGFB1 is linked to pulmonary arterial hypertension.